StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
8
Publishing Date
2024 - 03 - 15
9
2024 - 03 - 11
13
2024 - 03 - 04
11
2024 - 02 - 20
9
2024 - 02 - 13
9
2024 - 02 - 12
10
2024 - 01 - 08
10
2023 - 12 - 18
9
2023 - 12 - 07
9
2023 - 11 - 27
11
2023 - 10 - 31
10
2023 - 10 - 26
10
2023 - 10 - 02
11
2023 - 09 - 18
9
2023 - 09 - 12
9
2023 - 09 - 11
11
2023 - 09 - 06
10
2023 - 08 - 15
10
2023 - 08 - 01
10
2023 - 06 - 22
9
2023 - 05 - 01
15
2023 - 04 - 24
9
2023 - 03 - 08
10
2023 - 01 - 19
9
2022 - 12 - 22
9
2022 - 12 - 20
10
2022 - 10 - 06
9
2022 - 07 - 19
9
2022 - 07 - 11
9
2022 - 07 - 05
9
2022 - 05 - 31
14
2022 - 05 - 24
10
2022 - 05 - 02
10
2022 - 01 - 31
11
2022 - 01 - 18
16
2021 - 12 - 22
9
2021 - 12 - 21
12
2021 - 12 - 20
10
2021 - 12 - 09
11
2021 - 12 - 01
13
2021 - 11 - 30
10
2021 - 11 - 29
10
2021 - 11 - 01
12
2021 - 09 - 28
9
2021 - 09 - 20
11
2021 - 08 - 24
9
2021 - 07 - 29
10
2021 - 07 - 06
10
2021 - 06 - 29
9
2021 - 06 - 11
17
2021 - 06 - 01
13
2021 - 05 - 28
10
2021 - 04 - 21
10
2021 - 04 - 19
10
2021 - 04 - 13
8
2021 - 04 - 12
9
2021 - 03 - 01
8
2021 - 02 - 01
8
2021 - 01 - 19
8
2020 - 12 - 17
11
Sector
Health technology
7
Manufacturing
1
N/a
1
Tags
100
3
Acquire
3
Acquisition
3
Acute myeloid leukemia
3
Agreement
11
Alliances
3
America
5
Aml
5
Application
3
Award
4
Biomidwest
3
Biotech-bay
6
Biotechnology
6
Ceo
4
Change
4
Clinical-trials-phase-iii
4
Collaboration
5
Companies
4
Conference
6
Contract
6
Corporation
9
Cystic fibrosis
3
Drug
3
Energy
8
Fda
8
Financial
12
Genetown
4
Global
26
Group
5
Growth
13
Health
4
Index
7
Leukemia
5
Management
6
Market
42
Meeting
20
N/a
259
Nasdaq
5
One
4
Ongoing
8
Pharm-country
9
Pharmaceuticals
9
Phase 1
7
Positive
6
Potential
5
Preclinical
4
Program
7
Report
17
Repurchase
4
Research
9
Results
13
Software
4
Study
12
Technology
10
Therapeutics
14
Tour
5
Treatment
10
Trial
12
Update
8
Year
16
Entities
Avita medical, inc.
1
Avita therapeutics, inc.
1
Biotricity inc
1
Ideaya biosciences, inc.
1
Igm biosciences, inc.
1
Mirati therapeutics, inc.
1
Polypid ltd.
1
Sanofi
1
Vertex pharmaceuticals incorporated
1
Symbols
AVHHL
1
BTCY
1
IDYA
1
IGMS
1
MRTX
1
PYPD
1
RCEL
1
SNY
1
SNYNF
1
VRTX
1
Exchanges
Nasdaq
8
Crawled Date
2022 - 12 - 13
1
2022 - 12 - 12
7
Crawled Time
00:00
1
09:00
1
13:00
2
14:00
1
14:20
1
15:00
1
20:00
1
Source
www.biospace.com
5
www.globenewswire.com
1
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2022 - 12 - 12
tags :
Fda
save search
Mirati Therapeutics Announces U.S. FDA Accelerated Approval of KRAZATI™ (adagrasib) as a Targeted Treatment Option for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation
Published:
2022-12-12
(Crawled : 00:00)
- prnewswire.com
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
42.04%
|
O:
1.16%
H:
1.41%
C:
0.19%
krasg12
treatment
fda
lung
approval
therapeutics
cancer
IDEAYA Biosciences Announces Submission of IND Application to the U.S. FDA for PARG Development Candidate IDE161
Published:
2022-12-12
(Crawled : 20:00)
- biospace.com/
IDYA
|
$40.19
-2.38%
-2.44%
500K
|
Health Technology
|
144.48%
|
O:
0.18%
H:
3.14%
C:
0.95%
ide161
fda
candidate
application
submission
Biotricity Files FDA 510(k) for a new Form Factor of its Biotres Cardiac Monitoring Device to Expand its Revenue Growth
Published:
2022-12-12
(Crawled : 15:00)
- biospace.com/
BTCY
|
$1.25
4.17%
4.0%
87K
|
Manufacturing
|
-72.41%
|
O:
-0.68%
H:
18.04%
C:
5.54%
fda
device
cardiac
growth
AVITA Medical Submits FDA PMA Supplement to Further Expand Indication to Soft Tissue Repair
Published:
2022-12-12
(Crawled : 14:20)
- globenewswire.com
RCEL
|
$9.405
-3.04%
-3.14%
230K
|
Health Technology
|
46.3%
|
O:
1.59%
H:
4.37%
C:
3.18%
fda
medical
soft tissue
Vertex Announces Investigational New Drug (IND) Application for VX-522, mRNA Therapy for People With Cystic Fibrosis, Cleared by FDA
Published:
2022-12-12
(Crawled : 14:00)
- biospace.com/
VRTX
|
$393.1
-0.27%
-0.27%
880K
|
Health Technology
|
26.25%
|
O:
0.96%
H:
0.06%
C:
-0.33%
vx-522
fda
cleared
drug
application
mrna
therapy
cystic fibrosis
PolyPid Announces Scheduling of Type D Meeting with U.S. FDA to Discuss SHIELD I Phase 3 Results and Regulatory Pathway for D-PLEX₁₀₀ for the Prevention of Surgical Site Infections in Abdominal Colorectal Surgery
Published:
2022-12-12
(Crawled : 13:00)
- biospace.com/
PYPD
|
$4.45
3.29%
1.1K
|
Health Technology
|
508.76%
|
O:
-0.14%
H:
9.52%
C:
-1.37%
fda
meeting
infections
FDA Action Alert: Mirati, Coherus/Shanghai Junshi, Gilead and More
Published:
2022-12-12
(Crawled : 13:00)
- biospace.com/
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-2.21%
|
O:
-2.34%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-1.9%
|
O:
0.02%
H:
0.0%
C:
0.0%
fda
Medivir has completed a successful pre-IND meeting with the FDA
Published:
2022-12-12
(Crawled : 09:00)
- prnewswire.com
IGMS
|
News
|
$8.1
-11.96%
-13.58%
250K
|
Health Technology
|
-51.19%
|
O:
-0.9%
H:
3.0%
C:
2.36%
fda
meeting
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.